Business Daily from THE HINDU group of publications
Saturday, May 19, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Agri-Biz & Commodities - Cotton
Industry & Economy - Bio-tech & Genetics
An `event' that could be delayed

Harish Damodaran

New Delhi May 18 The GEAC's decision on May 11 to commercially approve 49 Bt cotton hybrids based on existing events has been justified by the Supreme Court's ruling only May 8. The Court had held that GEAC could clear the release of new GM hybrids, so long as they expressed the already approved gene constructs: Bollgard I and II, Event-1 and GFM event.

What the GEAC has, however, simultaneously done is to also block largescale trials (LST) of a new event (`9124') developed by Metahelix Life Sciences Pvt Ltd, a Bangalore-based venture that has Kotak India Growth Fund and Nadathur Holdings & Investments as angel investors. The latter is an investment firm promoted by Mr N.S. Raghavan, a cofounder of Infosys.

Metahelix had sought LST and seed production approval for three Bt cotton hybrids (5174, 3134 and 5125) incorporating its own in-house synthetic cry1c gene construct. "It is a completely different gene with a different mode of action from cry1Ac or cry1Ab. It is a single gene with a broad spectrum of activity, producing toxic proteins against both bollworms and armyworm," said Dr K.K. Narayanan, Managing Director of Metahelix.

While that makes it similar to Monsanto's Bollgard-II, "ours is a single gene (cry1c), whereas they are using two (cry1Ac and cry1Ab)". Moreover, "the protein length in our event is half that of other events, which means the plant has to spend only half the energy to produce the same number of effective protein molecules," claimed Dr Narayanan, a former Monsanto employee.

Metahelix's event has gone through the stages of laboratory and green house-level validations, besides contained field evaluation and multi-locational trials. "Last year, we held field trials in 19 locations all over India and the results were endorsed by the Department of Biotechnology's Review Committee of Genetic Manipulation and the Monitoring and Evaluation Committee. Despite this, the GEAC has not approved our LSTs for this season," he said.

The company would then have to wait till next year for LST approval, which means the new event will not reach the farmer before kharif 2010. Not good news, if one believes Dr Narayanan that "our technology has been developed at one-fourth the cost of the existing ones".

More Stories on : Cotton | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
NCDEX plans robusta cherry contracts relaunch


Pacific typhoon deflects monsoon flows
Inflation rate drops on cheaper manufactured items, fuel
Arecanut market dull on poor offtake
Mixed trend in spot rubber market
Nod for new Bt cotton strains may not spur competition
Foodgrain traders oppose tax plan
An `event' that could be delayed
Solvent extractors' team visiting Latin America
Vanilla prices likely to move up
Pepper futures up on lack of spot sales
Thin arrivals


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line